‘Dream Team’ Principal

Get Permission

Stand Up To Cancer is a groundbreaking initiative created to accelerate innovative cancer research that will rapidly bring new therapies to patients. In 2014, Margaret A. Tempro, MD, was selected to join a multidisciplinary Stand Up To Cancer “dream team” of pancreatic cancer researchers from nine institutions. Dr. Tempero will lead the University of California, San Francisco, portion of research, collaborating nationally to study vaccines and other immune-based strategies.

The project, titled “Transforming Pancreatic Cancer to a Treatable Disease,” is being funded by the Lustgarden Foundation and the Fox Family Cancer Research Funding Trust, along with administrative support and oversight from Stand Up To Cancer’s scientific partner, the American Association for Cancer Research. ■


Related Articles

Pancreatic Cancer in 2014

Adenocarcinoma of the pancreas is the fourth leading cause of cancer death in men and women in the United States. This year, about 46,000 people in this country will be diagnosed with pancreatic cancer, and more than 39,000 will die of the disease. The ASCO Post recently spoke with Margaret A....




By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.